Identifying urine biomarkers for early detection of aggressive bladder cancer
Project 3
This study is looking at bladder cancer, especially the non-muscle-invasive type, to find out how it can get worse and to create a simple urine test that helps identify patients who might be at risk for more serious problems before they show any symptoms, making it easier to manage their care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Methodist Hospital Research Institute NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10708912 on NIH RePORTER |
What this research studies
This research focuses on bladder cancer, particularly non-muscle-invasive bladder cancer (NMIBC), which is a common urologic malignancy. The project aims to understand the mechanisms that lead to the progression of NMIBC and to develop a non-invasive urine test that can identify patients at risk of aggressive disease before it becomes clinically apparent. By analyzing specific biological markers in urine, the researchers hope to create a 'fingerprint' that can help stratify patients based on their risk of progression. This approach could lead to earlier interventions and better management of bladder cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with non-muscle-invasive bladder cancer who are at risk of disease progression.
Not a fit: Patients with muscle-invasive bladder cancer or those without a diagnosis of bladder cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enable earlier detection and more personalized treatment for patients with bladder cancer, potentially improving outcomes.
How similar studies have performed: Previous research has shown promise in using biomarkers for cancer detection, suggesting that this approach could be effective, although this specific method is novel.
Where this research is happening
Houston, United States
- Methodist Hospital Research Institute — Houston, United States (Active)
Researchers
- Principal investigator: Furuya, Hideki — Methodist Hospital Research Institute
- Study coordinator: Furuya, Hideki
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.